|
LUZP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59099999996748E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.20369999999193E-05 |
| Normal-vs-Stage2 |
3.96810000000691E-05 |
| Normal-vs-Stage3 |
1.246580E-04 |
| Normal-vs-Stage4 |
1.21780030504226E-10 |
| Stage1-vs-Stage2 |
2.895400E-01 |
| Stage1-vs-Stage3 |
2.422600E-01 |
| Stage1-vs-Stage4 |
1.60040999999111E-05 |
| Stage2-vs-Stage3 |
9.851400E-01 |
| Stage2-vs-Stage4 |
3.812300E-02 |
| Stage3-vs-Stage4 |
4.022100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85870000005239E-06 |
| Normal-vs-AfricanAmerican |
5.73360000000189E-05 |
| Normal-vs-Asian |
2.761300E-04 |
| Caucasian-vs-AfricanAmerican |
6.279000E-01 |
| Caucasian-vs-Asian |
2.932000E-01 |
| AfricanAmerican-vs-Asian |
3.012000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16050000001466E-07 |
| Normal-vs-Female |
1.091590E-02 |
| Male-vs-Female |
3.740400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.25789999999515E-05 |
| Normal-vs-Extreme_Weight |
1.70369999996645E-06 |
| Normal-vs-Obese |
5.94699999999504E-05 |
| Normal-vs-Extreme_Obese |
2.709500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.959800E-01 |
| Normal_Weight-vs-Obese |
4.604600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.152400E-01 |
| Extreme_Weight-vs-Obese |
4.831200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.364200E-01 |
| Obese-vs-Extreme_Obese |
6.307800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.023400E-03 |
| Normal-vs-Age(41-60Yrs) |
5.387600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.71349999972459E-07 |
| Normal-vs-Age(81-100Yrs) |
7.42859999958156E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.910600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.809200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.064970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.040300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.922200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.172960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.69669999999989E-05 |
| Normal-VS-Type2 PRCC |
7.5165000001931E-08 |
| Normal-VS-KIRP CIMP |
1.873640E-02 |
| Normal-VS-Unclassified PRCC |
1.175390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.579560E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.559400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.538800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.601000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.808220E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.123000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.90929996654899E-09 |
| Normal-vs-N1 |
4.00550000000388E-05 |
| Normal-vs-N2 |
5.241900E-04 |
| N0-vs-N1 |
7.302000E-01 |
| N0-vs-N2 |
3.976000E-01 |
| N1-vs-N2 |
6.363600E-01 |
|
|
